Nektar Therapeutics DSO Ratio 2011-2025 | NKTR

Annual DSO Ratio Nektar Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
14.6	56.4	110	90.3	117	13.2	5.95	34.6	31.5	6.56	5.46	26.1	25.2

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
117	5.46	41.3

Quarterly DSO Ratio Nektar Therapeutics

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	22.3	-	96.9	93.9	106	93.5	131	151	118	72.7	68.3	99.2	115	144	129	64.5	92.5	3.63	57.9	4.79	2.99	13.2	38.2	38.2	39.4	43.7	27.6	46.2	30.4	80.3	9.88	16.8	2.48	11.5	13.5	6.53	3.34	6.01	15.9	25.1	28.8	22.4	27.3	28.6	16.6	26	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
151	2.48	50.8

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
AbCellera Biologics ABCL	202	$ 3.56	-2.51 %	$ 1.05 B	Canada
AC Immune SA ACIU	22.1	$ 2.82	-2.07 %	$ 229 M	Schweiz
ADiTx Therapeutics ADTX	621	$ 3.05	4.81 %	$ 40.2 K	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
Abeona Therapeutics ABEO	387	$ 4.81	-1.23 %	$ 103 M	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Amneal Pharmaceuticals AMRX	55.7	$ 11.96	0.13 %	$ 3.7 B	USA
Armata Pharmaceuticals ARMP	249	$ 5.88	1.03 %	$ 212 M	USA
Achieve Life Sciences ACHV	36.8	$ 4.69	-1.88 %	$ 93 M	USA
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	49.5	-	0.49 %	$ 251 B	Cayman-islands
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Ascendis Pharma A/S ASND	132	$ 206.12	-1.18 %	$ 5 B	Danmark
Alterity Therapeutics Limited ATHE	16.2 K	$ 3.36	-1.95 %	$ 8.08 B	Australia
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	25	-	-15.15 %	$ 60.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Baudax Bio BXRX	126	-	0.59 %	$ 63 K	USA
AbbVie ABBV	267	$ 226.39	-1.0 %	$ 400 B	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
CymaBay Therapeutics CBAY	182	-	-	$ 3.45 B	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
Adaptive Biotechnologies Corporation ADPT	81.3	$ 15.13	-13.34 %	$ 2.23 B	USA
Avid Bioservices CDMO	45.6	-	-	$ 789 M	USA
Biogen BIIB	57.9	$ 182.61	0.35 %	$ 26.6 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
BioMarin Pharmaceutical BMRN	82.8	$ 53.01	-1.51 %	$ 10.1 B	USA
Clearside Biomedical CLSD	61.7	-	-	$ 25.3 M	USA
Celsion Corporation CLSN	15.6	-	-6.63 %	$ 13.9 M	USA
Clovis Oncology CLVS	65.5	-	-7.23 %	$ 13 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Chimerix CMRX	588	-	-	$ 756 M	USA
Concert Pharmaceuticals CNCE	147	-	-	$ 401 M	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	169	$ 9.44	-1.82 %	$ 611 M	USA